ClinicalTrials.Veeva

Menu

Sodiumhexametaphosphate Versus MTA as Pulp Capping Material for Immature Permanent Teeth

M

Minia University

Status

Not yet enrolling

Conditions

Pulp Disease, Dental

Treatments

Other: MTA
Other: Pulp capping
Drug: Sodiumhexametaphosphate

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Sodiumhexametaphosphate will be used as capping material for dental pulp of immature permanent teeth

Enrollment

100 estimated patients

Sex

All

Ages

7 to 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • healthy children
  • cooperative children
  • deep carious lesion
  • traumatic pulp exposure
  • immature permanent teeth

Exclusion criteria

  • uncooperative children
  • children with systemic disorders
  • non vital immature permanent teeth

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

Sodiumhexametaphosphate
Experimental group
Treatment:
Drug: Sodiumhexametaphosphate
Other: Pulp capping
MTA
Active Comparator group
Treatment:
Other: MTA
Other: Pulp capping

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems